Is Savara Inc. (SVRA) a Buy, Sell, or Hold?
Savara Inc.
NASDAQ:SVRA
$5.69 USD
-$0.05 (-0.87%)
- Volume
- 1.86M
- Average Volume
- 1.61M
- Market Capitalization
- $1.17B
- P/E Ratio
- -10.16
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $7.01
- Year Low
- $2.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.47
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
24
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
39
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 2.31M
SVRA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
SVRA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 3.35 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.51 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 4.45 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.11 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.23 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.59 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | F-InKind | 5.5 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | S-Sale | 5.6813 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 3.35 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.51 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 4.45 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.59 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.23 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-06-22 | M-Exempt | 1.11 | 2026-06-22 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 3.35 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 4.45 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.11 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.23 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.59 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.51 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | F-InKind | 5.04 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 3.35 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.23 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.59 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.11 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 4.45 | 2026-03-20 |
| Lowrance David L | officer: Chief Financial Officer | 2026-03-18 | M-Exempt | 1.51 | 2026-03-20 |
| McCracken Joseph S | director | 2026-02-16 | M-Exempt | 1.76 | 2026-02-17 |
| McCracken Joseph S | director | 2026-02-16 | M-Exempt | 1.76 | 2026-02-17 |
| RAMSAY DAVID A | director | 2025-12-19 | S-Sale | 6.061 | 2025-12-19 |
| Lowrance David L | officer: Chief Financial Officer | 2025-12-14 | F-InKind | 6.92 | 2025-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2025-12-16 | G-Gift | 0 | 2025-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-14 | F-InKind | 6.92 | 2025-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-16 | G-Gift | 0 | 2025-12-16 |
| Lutz Robert Matthew | officer: Chief Operating Officer | 2025-12-14 | F-InKind | 6.92 | 2025-12-16 |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-12-14 | F-InKind | 6.92 | 2025-12-16 |
| Erickson Anne | officer: Chief Business Officer | 2025-12-14 | F-InKind | 6.92 | 2025-12-16 |
| Hawkins Richard J | director | 2025-12-09 | A-Award | 0 | 2025-12-11 |
| van Es-Johansson An | director | 2025-12-09 | A-Award | 0 | 2025-12-11 |
| Elam Nevan C | director | 2025-12-09 | A-Award | 0 | 2025-12-11 |
| RAMSAY DAVID A | director | 2025-12-09 | A-Award | 0 | 2025-12-11 |
| McCracken Joseph S | director | 2025-12-09 | A-Award | 0 | 2025-12-11 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-10 | G-Gift | 0 | 2025-12-11 |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-12-04 | F-InKind | 6.37 | 2025-12-04 |
| Elam Nevan C | director | 2025-12-02 | M-Exempt | 1.46 | 2025-12-04 |
| Elam Nevan C | director | 2025-12-02 | F-InKind | 5.81 | 2025-12-04 |
| Elam Nevan C | director | 2025-12-02 | M-Exempt | 1.46 | 2025-12-04 |
| Hawkins Richard J | director | 2025-11-14 | M-Exempt | 1.46 | 2025-11-17 |
| Hawkins Richard J | director | 2025-11-14 | M-Exempt | 1.46 | 2025-11-17 |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-10-20 | A-Award | 0 | 2025-10-22 |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-10-20 | A-Award | 4.11 | 2025-10-22 |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-10-17 | 0 | 2025-10-22 | |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-10-17 | 3.35 | 2025-10-22 | |
| Wasfi Yasmine | officer: Chief Medical Officer | 2025-10-17 | 4.13 | 2025-10-22 | |
| Hawkins Richard J | director | 2025-06-20 | P-Purchase | 2.044 | 2025-06-23 |
| McCracken Joseph S | director | 2025-05-29 | P-Purchase | 2.0825 | 2025-06-02 |
| RAMSAY DAVID A | director | 2025-03-31 | P-Purchase | 2.775 | 2025-04-01 |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 0 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 3.35 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 7.33 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 11 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 1.11 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 1.23 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 4.45 | 2025-03-21 | |
| McCabe Kathleen R. | officer: Chief Legal Officer | 2025-03-13 | 1.51 | 2025-03-21 | |
| Lutz Robert Matthew | officer: Chief Operating Officer | 2025-02-13 | F-InKind | 2.83 | 2025-02-14 |
| Erickson Anne | officer: Chief Business Officer | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Erickson Anne | officer: Chief Business Officer | 2024-12-13 | F-InKind | 3.21 | 2024-12-16 |
| Erickson Anne | officer: Chief Business Officer | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Parker Braden C. | officer: Chief Commercial Officer | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Parker Braden C. | officer: Chief Commercial Officer | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Lutz Robert Matthew | officer: Chief Operating Officer | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Lutz Robert Matthew | officer: Chief Operating Officer | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2024-12-13 | G-Gift | 0 | 2024-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2024-12-13 | F-InKind | 3.21 | 2024-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2024-12-16 | S-Sale | 3.3311 | 2024-12-16 |
| Lowrance David L | officer: Chief Financial Officer | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Pratt Raymond Dennis | officer: Chief Medical Officer | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Pratt Raymond Dennis | officer: Chief Medical Officer | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-13 | F-InKind | 3.21 | 2024-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-16 | S-Sale | 3.3057 | 2024-12-16 |
| Pauls Matthew | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-12 | A-Award | 3.35 | 2024-12-16 |
| Hawkins Richard J | director | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| Hawkins Richard J | director | 2024-12-16 | S-Sale | 3.3211 | 2024-12-16 |
| Elam Nevan C | director | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| van Es-Johansson An | director | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| McCracken Joseph S | director | 2024-12-12 | A-Award | 0 | 2024-12-16 |
| RAMSAY DAVID A | director | 2024-12-12 | A-Award | 0 | 2024-12-16 |